SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-315228
Filing Date
2013-08-01
Accepted
2013-08-01 16:55:00
Documents
3
Period of Report
2013-07-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d577904d8k.htm 8-K 21222
2 EX-3.1 d577904dex31.htm EX-3.1 26285
3 EX-3.2 d577904dex32.htm EX-3.2 132751
  Complete submission text file 0001193125-13-315228.txt   181489
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 131003292
SIC: 2834 Pharmaceutical Preparations